CTMX Next Earnings Date Notes

— CytomX Therapeutics (CTMX) is a clinical-stage biopharmaceutical company pioneering the development of novel cancer therapies by leveraging its proprietary Probody�ae technology platform. Probody therapeutics are designed to be activated specifically within the tumor microenvironment, aiming to maximize anti-tumor efficacy while reducing off-tumor toxicity. Investors should note that CytomX’s key value drivers are tied closely to progress within its pipeline, including updates from ongoing clinical trials and evidence of advancing candidates toward later-stage development or potential partnership milestones. Pay close attention to metrics such as cash runway & cash used in operations, as these reflect both financial health and the company’s capacity to fund R&D. Licensing revenue, collaboration updates with major partners (such as Bristol Myers Squibb), and any details on partnerships or new clinical programs are relevant performance indicators. Additionally, any changes in guidance on trial timelines, regulatory submissions, or pivotal data readout dates will help frame the company’s outlook & long-term success. As you tune in to the upcoming earnings call, listen for management commentary on pipeline progress, partnership status, and financial projections for further insight. The next projected earnings date for CTMX is 8/6/2026 after close (stay tuned for a confirmed earnings date once announced).

CTMX Next Earnings Date FAQ

On this page we presented the CTMX Next Earnings Date information for CytomX Therapeutics along with recent past earnings dates. For Q1 of 2026, CTMX reported earnings of -0.100/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, CTMX reported earnings of -0.220/share, with the earnings report taking place on 3/16/2026. For Q3 of 2025, CTMX reported earnings of -0.090/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, CTMX reported earnings of 0.000/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, CTMX reported earnings of 0.270/share, with the earnings report taking place on 5/12/2025. Based on these past earnings dates, the projected next earnings date for CTMX is 8/6/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as CytomX Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to CytomX Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research CytomX Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next CTMX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up CTMX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the CTMX next earnings date.